Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine - Dodick, DW; Doty, EG; Aurora, SK; Ruff, DD; Stauffer, VL; Jedynak, J (Cephalalgia, 2021)